Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Thoracic Disease|September 15, 2025
Management and survival outcomes of patients with postoperative recurrence of non-small cell lung cancer at isolated ipsilateral hilar or mediastinal lymph nodeKeiji Yamanashi, Masatsugu Hamaji, Ryo Miyata, et al.
Modern Rheumatology|July 26, 2017
Characteristics of functional impairment in patients with long-standing rheumatoid arthritis based on range of motion of joints: Baseline data from a multicenter prospective observational cohort study to evaluate the effectiveness of joint surgery in the treat-to-target eraToshihisa Kojima, Hajime Ishikawa, Sakae Tanaka, et al.
International Journal of Rheumatic Diseases|December 7, 2017
Validation and reliability of the Timed Up and Go test for measuring objective functional impairment in patients with long-standing rheumatoid arthritis: a cross-sectional studyToshihisa Kojima, Hajime Ishikawa, Sakae Tanaka, et al.
Surgery Today|December 4, 2025
Survival outcomes of alectinib in postoperative recurrent ALK-rearranged lung cancerRyo Miyata, Masatsugu Hamaji, Hiroyuki Kurakami, et al.
Developmental Cell|May 15, 2008
Patched1 haploinsufficiency increases adult bone mass and modulates Gli3 repressor activityShinsuke Ohba, Hiroshi Kawaguchi, Fumitaka Kugimiya, et al.
The EMBO Journal|December 6, 2003
Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member BimToru Akiyama, Phillippe Bouillet, Tsuyoshi Miyazaki, et al.
Scientific Reports|April 18, 2020
Imaging evaluation of the cartilage in rheumatoid arthritis patients with an x-ray phase imaging apparatus based on Talbot-Lau interferometryHiroyuki Yoshioka, Yuho Kadono, Yoon Taek Kim, et al.
FEBS Letters|May 22, 2014
Netrin-4 derived from murine vascular endothelial cells inhibits osteoclast differentiation in vitro and prevents bone loss in vivoYuichiro Enoki, Tsuyoshi Sato, Shinya Tanaka, et al.
Biochemical and Biophysical Research Communications|October 28, 2008
A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptorToru Fukuda, Kazuhiro Kanomata, Junya Nojima, et al.
Biochemical and Biophysical Research Communications|March 8, 2011
A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206HSatoshi Ohte, Masashi Shin, Hiroki Sasanuma, et al.
Pageof 9